Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Depreciation and Depletion (2009 - 2011)

Updated

Vistagen Therapeutics (VTGN) recorded Depreciation and Depletion of $200,000 in FY2026 (year ended Mar 31, 2026), unchanged from $200,000 in FY2025.

Analysis

Vistagen Therapeutics (VTGN) Depreciation and Depletion (2009 - 2011) Analysis & Trends

Starting with FY2009, Vistagen Therapeutics' Depreciation and Depletion history includes 6 fiscal years.

  • Annual Depreciation and Depletion has a three-year compound annual growth rate of 15.4% (FY2023 to FY2026).
  • Per Business Quant data, VTGN's Depreciation and Depletion was $200,000 in FY2025 (+57.5%), $127,000 in FY2024 (-2.3%) and $130,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 192.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 726.00 Mn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 132.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2011 999.00
Dec 31, 2010 107.00
Sep 30, 2010 -677,215.00
Jun 30, 2010 571,000.00
Mar 31, 2010 107,000.00
Dec 31, 2009 107,000.00
Sep 30, 2009 107,000.00
Jun 30, 2009 107,000.00
Mar 31, 2009 107,000.00
API Access

Vistagen Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=VTGN&period=max&api_key=YOUR_API_KEY